TTK Healthcare Share Price Today

TTK Healthcare completes sale of EVA and Good Home brands to Wipro for ₹256 crore

TTK Healthcare sold "EVA" and "Good Home" brands to Wipro Enterprises. Cash consideration received was ₹256 crore plus applicable GST. Definitive agreements were signed on July 23, 2026. Transaction closed on September 4, 2026.

TTK Healthcare tax auditor resigns citing ICAI eligibility norms

M/s Aiyar & Co. resigns as TTK Healthcare tax auditor effective August 26, 2026. Firm cites ICAI Peer Review Certificate restrictions on signing listed company audits. Resignation covers the tax audit assignment for Financial Year 2025-26. Board and Audit Committee to appoint a replacement auditor shortly.

TTK Healthcare Q1 Results: Net Profit Rises to ₹213M, EBITDA Margin Expands to 5.7% YoY

TTK Healthcare reported Q1 standalone net profit of 213M rupees, up from 130M rupees in the year-ago quarter. Revenue grew to 2.6B rupees from 2.3B rupees YoY. EBITDA surged to 147M rupees from 27M rupees, while EBITDA margin expanded sharply to 5.7% from 1.2% on a year-on-year basis, reflecting a significant improvement in operational performance.

TTK Healthcare declares ₹10 dividend, reappoints chairman

TTK Healthcare Limited concluded its 68th AGM on July 26, 2026, with shareholders approving a ₹10 per share dividend and the reappointment of T T Raghunathan as Executive Chairman for five years. The board also adopted FY26 financial statements and ratified cost auditor fees for M/s Geeyes & Co. The virtual meeting featured engagement from shareholders and compliance with SEBI and MCA guidelines.

TTK Healthcare to sell EVA and Good Home brands for ₹256 crore

TTK Healthcare has approved the sale of its EVA and Good Home brands to Wipro Enterprises Private Limited for ₹256 crore plus applicable GST. The definitive agreements were signed on July 23, 2026, and the transaction is expected to close by September 30, 2026, subject to customary conditions precedent. The divested brands contributed ₹148 crore, representing 17% of the company's total turnover in FY 2025-26.

Sunil Singhania's Abakkus Reports 2.07% Stake in TTK Healthcare in Q1

Sunil Singhania's investment firm Abakkus has reported a 2.07% stake in TTK Healthcare as per Q1 shareholding disclosures. The disclosure highlights institutional investor interest in the company. No additional transaction details, pricing information, or comparative shareholding data were available alongside the reported figures.